Details of Disease

General Information of Disease (ID: DIS6SVEE)

Disease Name	Syndromic disease
Synonyms	syndromic disease or disorder; syndromic disease; syndromes; syndrome associated with disease or disorder; syndrome; symptom clusters; symptom cluster; clusters, symptom; cluster, symptom
Disease Class	5C53: Inborn energy metabolism error
Definition	A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.
Disease Hierarchy	DISH7H5I: Human disease DIS6SVEE: Syndromic disease
ICD Code	ICD-11 ICD-11: 5C53.4 ICD-10 ICD-10: E72.8
Disease Identifiers	MONDO ID MONDO_0002254 MESH ID D013577 UMLS CUI C0039082 MedGen ID 11688

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
P-2202	DM6MCJ0	Phase 2	NA	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
AB-3001	DMO5ME2	Investigative	NA	[2]
HL-035	DMG7BRT	Investigative	NA	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	ClinicalTrials.gov (NCT01674348) A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes. U.S. National Institutes of Health.
2	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.